Report Detail

Request for Sample of this report

Chemical & Material Global Deferasirox API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4638790
    • |
  • 24 October, 2025
    • |
  • Global
    • |
  • 126 Pages
    • |
  • GIR
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Deferasirox API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Deferasirox is a synthetic, orally bioavailable, achiral, tridentate triazole derived from salicylic acid with iron-chelating activity. Deferasirox chelates iron at a 2:1 (ligand:iron) ratio. Because of its oral availability and long plasma half-life, this agent may be superior to desferrioxamine (desferal, DFO), which is orally inactive and has a short plasma half-life.
This report is a detailed and comprehensive analysis for global Deferasirox API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Deferasirox API market size and forecasts, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2020-2031
Global Deferasirox API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2020-2031
Global Deferasirox API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2020-2031
Global Deferasirox API market shares of main players, shipments in revenue ($ Million), sales quantity (Kiloton), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Deferasirox API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Deferasirox API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Piramal Enterprises Limited, Alkaloids Corporation, Zhejiang Hengkang Pharmaceutical, Om Pharmaceutical Industries, Teva API, Symed Labs Limited, Neuland Laboratories, Parabolic Drugs Limited, YUNG ZIP CHEMICAL INDUSTRIAL, Erregierre SpA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Deferasirox API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥98%
Purity<98%
Market segment by Application
Deferasirox Tablets
Others
Major players covered
Piramal Enterprises Limited
Alkaloids Corporation
Zhejiang Hengkang Pharmaceutical
Om Pharmaceutical Industries
Teva API
Symed Labs Limited
Neuland Laboratories
Parabolic Drugs Limited
YUNG ZIP CHEMICAL INDUSTRIAL
Erregierre SpA
Glenmark Pharmaceuticals
Cipla
Sun Pharmaceutical Industries Ltd.
Jubilant Pharma
CTX Lifesciences
Waterstone Pharmaceuticals Inc.
Bal Pharma Ltd.
Curequest Lifescience
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Deferasirox API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Deferasirox API, with price, sales quantity, revenue, and global market share of Deferasirox API from 2020 to 2025.
Chapter 3, the Deferasirox API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Deferasirox API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Deferasirox API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Deferasirox API.
Chapter 14 and 15, to describe Deferasirox API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Deferasirox API Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Purity≥98%
    • 1.3.3 Purity<98%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Deferasirox API Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Deferasirox Tablets
    • 1.4.3 Others
  • 1.5 Global Deferasirox API Market Size & Forecast
    • 1.5.1 Global Deferasirox API Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Deferasirox API Sales Quantity (2020-2031)
    • 1.5.3 Global Deferasirox API Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Piramal Enterprises Limited
    • 2.1.1 Piramal Enterprises Limited Details
    • 2.1.2 Piramal Enterprises Limited Major Business
    • 2.1.3 Piramal Enterprises Limited Deferasirox API Product and Services
    • 2.1.4 Piramal Enterprises Limited Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Piramal Enterprises Limited Recent Developments/Updates
  • 2.2 Alkaloids Corporation
    • 2.2.1 Alkaloids Corporation Details
    • 2.2.2 Alkaloids Corporation Major Business
    • 2.2.3 Alkaloids Corporation Deferasirox API Product and Services
    • 2.2.4 Alkaloids Corporation Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Alkaloids Corporation Recent Developments/Updates
  • 2.3 Zhejiang Hengkang Pharmaceutical
    • 2.3.1 Zhejiang Hengkang Pharmaceutical Details
    • 2.3.2 Zhejiang Hengkang Pharmaceutical Major Business
    • 2.3.3 Zhejiang Hengkang Pharmaceutical Deferasirox API Product and Services
    • 2.3.4 Zhejiang Hengkang Pharmaceutical Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
  • 2.4 Om Pharmaceutical Industries
    • 2.4.1 Om Pharmaceutical Industries Details
    • 2.4.2 Om Pharmaceutical Industries Major Business
    • 2.4.3 Om Pharmaceutical Industries Deferasirox API Product and Services
    • 2.4.4 Om Pharmaceutical Industries Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Om Pharmaceutical Industries Recent Developments/Updates
  • 2.5 Teva API
    • 2.5.1 Teva API Details
    • 2.5.2 Teva API Major Business
    • 2.5.3 Teva API Deferasirox API Product and Services
    • 2.5.4 Teva API Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Teva API Recent Developments/Updates
  • 2.6 Symed Labs Limited
    • 2.6.1 Symed Labs Limited Details
    • 2.6.2 Symed Labs Limited Major Business
    • 2.6.3 Symed Labs Limited Deferasirox API Product and Services
    • 2.6.4 Symed Labs Limited Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Symed Labs Limited Recent Developments/Updates
  • 2.7 Neuland Laboratories
    • 2.7.1 Neuland Laboratories Details
    • 2.7.2 Neuland Laboratories Major Business
    • 2.7.3 Neuland Laboratories Deferasirox API Product and Services
    • 2.7.4 Neuland Laboratories Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Neuland Laboratories Recent Developments/Updates
  • 2.8 Parabolic Drugs Limited
    • 2.8.1 Parabolic Drugs Limited Details
    • 2.8.2 Parabolic Drugs Limited Major Business
    • 2.8.3 Parabolic Drugs Limited Deferasirox API Product and Services
    • 2.8.4 Parabolic Drugs Limited Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Parabolic Drugs Limited Recent Developments/Updates
  • 2.9 YUNG ZIP CHEMICAL INDUSTRIAL
    • 2.9.1 YUNG ZIP CHEMICAL INDUSTRIAL Details
    • 2.9.2 YUNG ZIP CHEMICAL INDUSTRIAL Major Business
    • 2.9.3 YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Product and Services
    • 2.9.4 YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 YUNG ZIP CHEMICAL INDUSTRIAL Recent Developments/Updates
  • 2.10 Erregierre SpA
    • 2.10.1 Erregierre SpA Details
    • 2.10.2 Erregierre SpA Major Business
    • 2.10.3 Erregierre SpA Deferasirox API Product and Services
    • 2.10.4 Erregierre SpA Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Erregierre SpA Recent Developments/Updates
  • 2.11 Glenmark Pharmaceuticals
    • 2.11.1 Glenmark Pharmaceuticals Details
    • 2.11.2 Glenmark Pharmaceuticals Major Business
    • 2.11.3 Glenmark Pharmaceuticals Deferasirox API Product and Services
    • 2.11.4 Glenmark Pharmaceuticals Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Glenmark Pharmaceuticals Recent Developments/Updates
  • 2.12 Cipla
    • 2.12.1 Cipla Details
    • 2.12.2 Cipla Major Business
    • 2.12.3 Cipla Deferasirox API Product and Services
    • 2.12.4 Cipla Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Cipla Recent Developments/Updates
  • 2.13 Sun Pharmaceutical Industries Ltd.
    • 2.13.1 Sun Pharmaceutical Industries Ltd. Details
    • 2.13.2 Sun Pharmaceutical Industries Ltd. Major Business
    • 2.13.3 Sun Pharmaceutical Industries Ltd. Deferasirox API Product and Services
    • 2.13.4 Sun Pharmaceutical Industries Ltd. Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
  • 2.14 Jubilant Pharma
    • 2.14.1 Jubilant Pharma Details
    • 2.14.2 Jubilant Pharma Major Business
    • 2.14.3 Jubilant Pharma Deferasirox API Product and Services
    • 2.14.4 Jubilant Pharma Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Jubilant Pharma Recent Developments/Updates
  • 2.15 CTX Lifesciences
    • 2.15.1 CTX Lifesciences Details
    • 2.15.2 CTX Lifesciences Major Business
    • 2.15.3 CTX Lifesciences Deferasirox API Product and Services
    • 2.15.4 CTX Lifesciences Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 CTX Lifesciences Recent Developments/Updates
  • 2.16 Waterstone Pharmaceuticals Inc.
    • 2.16.1 Waterstone Pharmaceuticals Inc. Details
    • 2.16.2 Waterstone Pharmaceuticals Inc. Major Business
    • 2.16.3 Waterstone Pharmaceuticals Inc. Deferasirox API Product and Services
    • 2.16.4 Waterstone Pharmaceuticals Inc. Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Waterstone Pharmaceuticals Inc. Recent Developments/Updates
  • 2.17 Bal Pharma Ltd.
    • 2.17.1 Bal Pharma Ltd. Details
    • 2.17.2 Bal Pharma Ltd. Major Business
    • 2.17.3 Bal Pharma Ltd. Deferasirox API Product and Services
    • 2.17.4 Bal Pharma Ltd. Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Bal Pharma Ltd. Recent Developments/Updates
  • 2.18 Curequest Lifescience
    • 2.18.1 Curequest Lifescience Details
    • 2.18.2 Curequest Lifescience Major Business
    • 2.18.3 Curequest Lifescience Deferasirox API Product and Services
    • 2.18.4 Curequest Lifescience Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Curequest Lifescience Recent Developments/Updates

3 Competitive Environment: Deferasirox API by Manufacturer

  • 3.1 Global Deferasirox API Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Deferasirox API Revenue by Manufacturer (2020-2025)
  • 3.3 Global Deferasirox API Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Deferasirox API by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Deferasirox API Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Deferasirox API Manufacturer Market Share in 2024
  • 3.5 Deferasirox API Market: Overall Company Footprint Analysis
    • 3.5.1 Deferasirox API Market: Region Footprint
    • 3.5.2 Deferasirox API Market: Company Product Type Footprint
    • 3.5.3 Deferasirox API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Deferasirox API Market Size by Region
    • 4.1.1 Global Deferasirox API Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Deferasirox API Consumption Value by Region (2020-2031)
    • 4.1.3 Global Deferasirox API Average Price by Region (2020-2031)
  • 4.2 North America Deferasirox API Consumption Value (2020-2031)
  • 4.3 Europe Deferasirox API Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Deferasirox API Consumption Value (2020-2031)
  • 4.5 South America Deferasirox API Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Deferasirox API Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Deferasirox API Sales Quantity by Type (2020-2031)
  • 5.2 Global Deferasirox API Consumption Value by Type (2020-2031)
  • 5.3 Global Deferasirox API Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Deferasirox API Sales Quantity by Application (2020-2031)
  • 6.2 Global Deferasirox API Consumption Value by Application (2020-2031)
  • 6.3 Global Deferasirox API Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Deferasirox API Sales Quantity by Type (2020-2031)
  • 7.2 North America Deferasirox API Sales Quantity by Application (2020-2031)
  • 7.3 North America Deferasirox API Market Size by Country
    • 7.3.1 North America Deferasirox API Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Deferasirox API Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Deferasirox API Sales Quantity by Type (2020-2031)
  • 8.2 Europe Deferasirox API Sales Quantity by Application (2020-2031)
  • 8.3 Europe Deferasirox API Market Size by Country
    • 8.3.1 Europe Deferasirox API Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Deferasirox API Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Deferasirox API Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Deferasirox API Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Deferasirox API Market Size by Region
    • 9.3.1 Asia-Pacific Deferasirox API Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Deferasirox API Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Deferasirox API Sales Quantity by Type (2020-2031)
  • 10.2 South America Deferasirox API Sales Quantity by Application (2020-2031)
  • 10.3 South America Deferasirox API Market Size by Country
    • 10.3.1 South America Deferasirox API Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Deferasirox API Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Deferasirox API Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Deferasirox API Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Deferasirox API Market Size by Country
    • 11.3.1 Middle East & Africa Deferasirox API Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Deferasirox API Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Deferasirox API Market Drivers
  • 12.2 Deferasirox API Market Restraints
  • 12.3 Deferasirox API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Deferasirox API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Deferasirox API
  • 13.3 Deferasirox API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Deferasirox API Typical Distributors
  • 14.3 Deferasirox API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Deferasirox API. Industry analysis & Market Report on Deferasirox API is a syndicated market report, published as Global Deferasirox API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Deferasirox API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo